! 
i 
i 
Status 
(Open/ 
Closed) 
Open 
P/FDA 
for 
addit- 
ional 3 
Open 
P/FDA 
Open 
< E 
S 
P/FDA 
Open 
Open 
P/FDA 
and NIH 
P/FDA 
P/FDA 
£ 
* 8 
Q 
o 
o 
Oh 
Oh 
Oh 
Oh 
Oh 
Oh 
o 
z; 
Oh 
Oh 
Oh 
Adverse 
Effects 
Oh 
No 
Oh 
Oh 
Oh 
Oh 
Oh 
Oh 
No 
Oh 
Oh 
Oh 
Problems 
with Gene 
Transfer 
Oh 
No 
Oh 
Oh 
Oh 
Oh 
Oh 
Oh 
No 
Oh 
Oh 
Oh 
In Vivo 
Evidence 
of Gene 
Transfer 
(Human) 
Oh 
Yes 
Oh 
Oh 
Oh 
Oh 
Oh 
Oh 
No 
Oh 
Oh 
Oh 
Patient 
Accrual 
To 
Date 
C* 
o 
° 
<N 
o 
o 
o 
- 
o 
O 
O 
e „ _ 
g c S 
E M s 
8 
Oh 
a 
3 
s 
a 
O 
8 
8 
24 (12 
intra tumor 
and 12 
catheter) 
»/■> 
Vector 
Supplier 
U. of PA 
Genzyme 
GTI 
LLD 
LLO 
GTI 
U. of MI 
Viagcne 
ATCC 
Vical 
U. of 
Pitts- 
burgh 
Packag- 
ing Cell 
293 
293 
PA317 
PA317 
PA317 
293 
293 
D 
5 
> 
PA317 
NA 
Y-crip 
Vector/ 
Gene 
S&l 
u 
< 
GITKSvNa 
3S o£ 
o o 
v v 
^1 5. 
|“5 
5 5 
* 
1 8 
ri 2 
3 O 
MFG-hu- 
GM-CSF 
AvlCF2 
(type 5) 
Ad.CB-CFTR 
(type 5) 
pHUy-IFN 
MDR-1 
cDNA/LN 
Cationic 
liposome 
(pHLA-B7/ 
P-2 
3 
■8 
1- 
R-GC 
Date 
First 
Patient 
Treated: 
9-3-93 
7-26-93 
Oh 
Oh 
10/12/93 
Oh 
Oh 
Oh 
1 
o b 
Oh 
Oh 
Oh 
Patients 
CF 
CF 
Cancer/ 
Brain 
BMM/ 
Leukemia 
BMM/ 
AML 
Cancer/ 
Renal Cell 
CF 
CF 
1 Cancer/ 1 
| Melanoma | 
Cancer/ 
Ovarian 
Cancer 
Gaucher 
Disease 
M/T 
H 
2 
H 
2 
2 
H 
H 
H 
H 
H 
H 
H 
NIH 
Approval 
Date 
8-26-93 
4-16-93 
4-16-93 
4-16-93 
4-16-93 
Oa 
4-16-93 
10-7-93 
g 
$ 
Oh 
9-3-93 
9-3-93 
RAC 
Approval 
Date 
g 
12-4-92 
3-1-93 
3-2-93 
8 
A 
3-1-93 
<4 
8 
c5| 
rh 
6-7-93 
6-7-93 
6-7-93 
6-7-93 
Institution 
U. of PA 
HHMI 
Iowi 
Methodist 
and U. of 
IA 
St. Jude 
St. Jude 
Johns 
Hopkins 
Children's 
Hospital, 
OH 
U. of NC 
Duke U. 
MD 
Anderson 
U. of MI 
U. of 
Pittsburgh 
S',- • 
CU 
Wilson 
Welsh, et. al 
Culver, et. 
al. 
Heslop 
Brenner, et. 
al 
Simons 
Wilmott, et. 
al. 1 
Boucher, et. 
al. 
Seigler 
Deisseroth, 
et. al. 
Nabel 
Barranger 
eo 
<0 
g 
§ 
8 
cn 
1 
8 : 
H 
1 
1 
1 
1 
1 
P 
l 
I | 
Recombinant DNA Research, Volume 18 
[585] 
